【结 构 式】 |
【分子编号】28249 【品名】2-[3-benzyl-8-(benzyloxy)-2-ethyl-1-indolizinyl]acetamide 【CA登记号】 |
【 分 子 式 】C26H26N2O2 【 分 子 量 】398.50472 【元素组成】C 78.36% H 6.58% N 7.03% O 8.03% |
合成路线1
该中间体在本合成路线中的序号:(IX)Acidic hydrolysis of the cladinose sugar of 6-O-allylerythromycin A (III) with HCl in ethanol/water yields the 3-hydroxy intermediate (IX), which is first protected at the 2'-OH group with acetic anhydride or benzoyl anhydride to (Xa) or (Xb) and then oxidized with NCS and dimethyl sulfide to the 3-oxoerythromycin derivatives (XIa) or (XIb). The reaction of (XIa) with CDI and LiH or (XIb) first with CDI and NaHMDS, then with DBU and finally with CDI and NaH, provides the 12-O-(1-imidazolylcarbonyl)erythromycin derivatives (XIIa) and (XIIb), which are cyclized with aqueous ammonia to the cyclic carbamates (VII) and (XIIIb). Finally, these compounds are condensed with 3-bromoquinoline (VIII) by means of palladium acetate, tris(o-tolyl)phosphine and Et3N in acetonitrile and deprotected with methanol 60-80%.
【1】 Ma, Z.; et al.; Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. J Med Chem 2001, 44, 24, 4137. |
【2】 Or, Y.; Clark, R.F.; Ma, Z.; Design, synthesis, and characterization of ABT-773: A novel ketolide highly active against multidrug-resistant pathogens. 39th Intersci Conf Antimicrob Agents Chemother (Sept 26 1999, San Francisco) 1999, Abst F2133. |
【3】 Ewing, P.; Or, Y.S.; Nilius, A.M.; Wang, S.; Clark, R.F.; Alder, J.; Chu, D.T.W.; Mitten, M.; Flamm, R.K.; Ma, Z.; Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. J Med Chem 2000, 43, 6, 1045-49. |
【4】 Rabasseda, X.; Sorbera, L.A.; Castañer, J.; ABT-773. Drugs Fut 2000, 25, 5, 445. |
【5】 Or, Y.S.; Ma, Z.; Clark, R.F.; Chu, D.T.; Plattner, J.J. (Abbott Laboratories Inc.); 6-O-Substd. ketolides having antibacterial activity. EP 0929563; US 5866549; WO 9809978 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(Xb) | 28430 | (2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-14-ethyl-4,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecanyl]oxy]-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl benzoate | C39H61NO11 | 详情 | 详情 | |
(XIb) | 28431 | (2S,3R,4S,6R)-2-[[(3R,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-14-ethyl-12,13-dihydroxy-3,5,7,9,11,13-hexamethyl-2,4,10-trioxooxacyclotetradecanyl]oxy]-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl benzoate | C39H59NO11 | 详情 | 详情 | |
(Xa) | 35296 | (2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-14-ethyl-4,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecanyl]oxy]-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl acetate | C34H59NO11 | 详情 | 详情 | |
(XIa) | 35297 | (2S,3R,4S,6R)-2-[[(3R,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-14-ethyl-12,13-dihydroxy-3,5,7,9,11,13-hexamethyl-2,4,10-trioxooxacyclotetradecanyl]oxy]-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl acetate | C34H57NO11 | 详情 | 详情 | |
(XIIa) | 35298 | (2R,3S,7R,9S,10R,11R,13R)-10-[[(2S,3R,4S,6R)-3-(acetoxy)-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy]-9-(allyloxy)-2-ethyl-3,5,7,9,11,13-hexamethyl-6,12,14-trioxooxa-4-cyclotetradecen-3-yl 1H-imidazole-1-carboxylate | C38H57N3O11 | 详情 | 详情 | |
(XIIb) | 35299 | (2R,3S,7R,9S,10R,11R,13R)-9-(allyloxy)-10-[[(2S,3R,4S,6R)-3-(benzoyloxy)-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-2-yl]oxy]-2-ethyl-3,5,7,9,11,13-hexamethyl-6,12,14-trioxooxa-4-cyclotetradecen-3-yl 1H-imidazole-1-carboxylate | C43H59N3O11 | 详情 | 详情 | |
(XIIIb) | 35300 | (2S,3R,4S,6R)-2-[[(3aS,4R,7R,9R,10R,11S,13R,15R,15aR)-11-(allyloxy)-4-ethyl-3a,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxotetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-10-yl]oxy]-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl benzoate | C40H58N2O11 | 详情 | 详情 | |
(III) | 28391 | (3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-6-[[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-14-ethyl-12,13-dihydroxy-4-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy]-3,5,7,9,11,13-hexamethyl-2,10-oxacyclotetradecanedione | C40H71NO13 | 详情 | 详情 | |
(VII) | 35295 | C35H56N2O11 | 详情 | 详情 | ||
(VIII) | 28432 | 3-bromoquinoline | 5332-24-1 | C9H6BrN | 详情 | 详情 |
(IX) | 28249 | 2-[3-benzyl-8-(benzyloxy)-2-ethyl-1-indolizinyl]acetamide | C26H26N2O2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(IX)The hydrogenation of pyridineacrylate (I) produced a mixture of the benzyl-protected pyridinepropionate (II) and the debenzylated analogue (III), which were separated by column chromatography. Ester (III) was converted into amide (IV) upon treatment with aqueous ammonia, and further protected with benzyl chloride to afford (V). Cyclization with 1-bromo-2-butanone (VI) in the presence of NaHCO3 furnished indolizidine (VII). This was acylated with benzoyl chloride in boiling benzene to give ketone (VIII), which was reduced to the benzyl derivative (IX) by means of borane-tert-butyl amine complex and AlCl3. Hydrogenolytic deprotection of the benzyl ether of (IX) afforded phenol (X), which was alkylated with methyl bromoacetate and NaH to yield the corresponding esther (XI). Finally, hydrolysis of the methyl ester (XI) with LiOH provided the target carboxylic acid.
【1】 Hagishita, S.; Yamda, M.; Shirahase, K.; et al.; Potent inhibitors of secretory phospholipase A2: Synthesis and inhibitory activities on indolizine and indene derivatives. J Med Chem 1996, 39, 19, 3636. |
【2】 Dillard, R.D.; Hagishita, S.; Ohtani, M. (Eli Lilly and Company; Shionogi & Co. Ltd.); Indolizine sPLA2 inhibitors. EP 0772596; JP 1998505584; WO 9603383 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 28241 | ethyl (E)-3-[3-(benzyloxy)-2-pyridinyl]-2-propenoate | C17H17NO3 | 详情 | 详情 | |
(II) | 28242 | ethyl 3-[3-(benzyloxy)-2-pyridinyl]propanoate | C17H19NO3 | 详情 | 详情 | |
(III) | 28243 | ethyl 3-(3-hydroxy-2-pyridinyl)propanoate | C10H13NO3 | 详情 | 详情 | |
(IV) | 28244 | 3-(3-hydroxy-2-pyridinyl)propanamide | C8H10N2O2 | 详情 | 详情 | |
(V) | 28245 | 3-[3-(benzyloxy)-2-pyridinyl]propanamide | C15H16N2O2 | 详情 | 详情 | |
(VI) | 28246 | 1-bromo-2-butanone | 816-40-0 | C4H7BrO | 详情 | 详情 |
(VII) | 28247 | 2-[8-(benzyloxy)-2-ethyl-1-indolizinyl]acetamide | C19H20N2O2 | 详情 | 详情 | |
(VIII) | 28248 | 2-[3-benzoyl-8-(benzyloxy)-2-ethyl-1-indolizinyl]acetamide | C26H24N2O3 | 详情 | 详情 | |
(IX) | 28249 | 2-[3-benzyl-8-(benzyloxy)-2-ethyl-1-indolizinyl]acetamide | C26H26N2O2 | 详情 | 详情 | |
(X) | 28250 | 2-(3-benzyl-2-ethyl-8-hydroxy-1-indolizinyl)acetamide | C19H20N2O2 | 详情 | 详情 | |
(XI) | 28251 | methyl 2-[[1-(2-amino-2-oxoethyl)-3-benzyl-2-ethyl-8-indolizinyl]oxy]acetate | C22H24N2O4 | 详情 | 详情 |